News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

QLT Inc. (QLTI) Gets Rights to Sell Visudyne in US from Novartis Pharma AG (NVS) (JOBS)


10/19/2009 6:23:07 AM

Bookmark and Share

Reuters -- Canadian eye-care company QLT Inc said it restructured its pact with Novartis Pharma AG, giving it exclusive rights to sell anti-blindness treatment Visudyne in the United States.

Read at Reuters
Read at Wall Street Journal
Read at Canadian Press

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES